R P Witherspoon
Overview
Explore the profile of R P Witherspoon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
109
Citations
2525
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Deeg H, Leisenring W, Storb R, NIMS J, Flowers M, Witherspoon R, et al.
Blood
. 1998 Jun;
91(10):3637-45.
PMID: 9572999
We reviewed the records and reevaluated 212 patients with aplastic anemia transplanted at the Fred Hutchinson Cancer Research Center (FHCRC) between 1970 and 1993 who survived >/=2 years and who...
12.
Storek J, Gooley T, Siadak M, Bensinger W, Maloney D, Chauncey T, et al.
Blood
. 1998 Jan;
90(12):4705-9.
PMID: 9389685
Chronic graft-versus-host disease (GVHD) is likely caused by donor T lymphocytes. Because unmodified blood stem cell grafts contain one log more T lymphocytes than unmodified marrow grafts, we evaluated the...
13.
Storek J, Mendelman P, Witherspoon R, McGregor B, Storb R
Clin Infect Dis
. 1997 Dec;
25(5):1253-5.
PMID: 9402399
No abstract available.
14.
Storek J, Witherspoon R, Maloney D, Chauncey T, Storb R
Blood
. 1997 May;
89(10):3891-3.
PMID: 9160701
No abstract available.
15.
Storb R, Leisenring W, Anasetti C, Appelbaum F, Buckner C, Bensinger W, et al.
Blood
. 1997 May;
89(10):3890-1.
PMID: 9160700
No abstract available.
16.
Deeg H, Lin D, Leisenring W, Boeckh M, Anasetti C, Appelbaum F, et al.
Blood
. 1997 May;
89(10):3880-7.
PMID: 9160697
Patients with a lymphohematopoietic malignancy considered to be at high risk for posttransplant relapse were enrolled in a study to compare the use of cyclosporine (CSP) as a single agent...
17.
Slattery J, Clift R, Buckner C, Radich J, Storer B, Bensinger W, et al.
Blood
. 1997 Apr;
89(8):3055-60.
PMID: 9108427
The influence of busulfan (BU) plasma concentration on outcome of transplantation from HLA identical family members for the treatment of chronic myelogenous leukemia (CML) was examined in 45 patients transplanted...
18.
Curtis R, Rowlings P, Deeg H, Shriner D, Socie G, Travis L, et al.
N Engl J Med
. 1997 Mar;
336(13):897-904.
PMID: 9070469
Background: The late effects of bone marrow transplantation, including cancer, need to be determined in a large population at risk. Methods: We studied 19,229 patients who received allogeneic transplants (97.2...
19.
Storek J, Gooley T, Witherspoon R, Sullivan K, Storb R
Am J Hematol
. 1997 Feb;
54(2):131-8.
PMID: 9034287
Survivors of allogeneic marrow transplants are immunodeficient for at least 1 year after grafting. Multiple defects of immunity have been found; however, it is not known which defect primarily accounts...
20.
Storek J, Witherspoon R, Storb R
Blood
. 1997 Jan;
89(1):350-1.
PMID: 8978315
No abstract available.